RDY logo

RDY Cash from financing

annual CFF:

$140.23M+$185.68M(+408.49%)
March 1, 2025

Summary

  • As of today (May 29, 2025), RDY annual cash flow from financing activities is $140.23 million, with the most recent change of +$185.68 million (+408.49%) on March 1, 2025.
  • During the last 3 years, RDY annual CFF has risen by +$172.74 million (+531.30%).
  • RDY annual CFF is now -77.32% below its all-time high of $618.26 million, reached on March 31, 2006.

Performance

RDY Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRDYcash flow metrics

quarterly CFF:

-$170.86M-$175.28M(-3966.43%)
March 1, 2025

Summary

  • As of today (May 29, 2025), RDY quarterly cash flow from financing activities is -$170.86 million, with the most recent change of -$175.28 million (-3966.43%) on March 1, 2025.
  • Over the past year, RDY quarterly CFF has dropped by -$164.19 million (-2464.08%).
  • RDY quarterly CFF is now -128.10% below its all-time high of $608.03 million, reached on March 31, 2006.

Performance

RDY quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRDYcash flow metrics

TTM CFF:

$140.23M-$164.19M(-53.94%)
March 1, 2025

Summary

  • As of today (May 29, 2025), RDY TTM cash flow from financing activities is $140.23 million, with the most recent change of -$164.19 million (-53.94%) on March 1, 2025.
  • Over the past year, RDY TTM CFF has increased by +$185.68 million (+408.50%).
  • RDY TTM CFF is now -80.44% below its all-time high of $716.91 million, reached on December 31, 2006.

Performance

RDY TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRDYcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

RDY Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+408.5%-2464.1%+408.5%
3 y3 years+531.3%-352.0%+531.3%
5 y5 years+139.6%-328.3%+139.6%

RDY Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+141.9%-188.8%at low-61.5%+141.9%
5 y5-yearat high+139.6%-188.8%at low-61.5%+139.6%
alltimeall time-77.3%+139.6%-128.1%+24.6%-80.4%+127.2%

RDY Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
$140.23M(-408.5%)
-$170.86M(-3966.4%)
$140.23M(-53.9%)
Dec 2024
-
$4.42M(-97.7%)
$304.42M(-16.4%)
Sep 2024
-
$192.30M(+68.1%)
$364.16M(+319.2%)
Jun 2024
-
$114.37M(-1816.3%)
$86.88M(-291.1%)
Mar 2024
-$45.46M(-86.4%)
-$6.66M(-110.4%)
-$45.46M(-54.1%)
Dec 2023
-
$64.15M(-175.5%)
-$99.05M(-33.0%)
Sep 2023
-
-$84.98M(+373.0%)
-$147.85M(-30.6%)
Jun 2023
-
-$17.97M(-70.2%)
-$213.01M(-36.4%)
Mar 2023
-$335.03M(+930.4%)
-$60.26M(-492.3%)
-$335.03M(+61.9%)
Dec 2022
-
$15.36M(-110.2%)
-$206.97M(-19.1%)
Sep 2022
-
-$150.14M(+7.3%)
-$255.82M(+25.9%)
Jun 2022
-
-$139.98M(-306.5%)
-$203.16M(+524.8%)
Mar 2022
-$32.51M(+711.4%)
$67.79M(-302.4%)
-$32.51M(-296.6%)
Dec 2021
-
-$33.49M(-65.6%)
$16.54M(-131.6%)
Sep 2021
-
-$97.48M(-417.9%)
-$52.26M(-22.7%)
Jun 2021
-
$30.66M(-73.8%)
-$67.60M(+1587.3%)
Mar 2021
-$4.01M(-98.9%)
$116.84M(-214.2%)
-$4.01M(-91.3%)
Dec 2020
-
-$102.28M(-9.3%)
-$46.02M(-73.0%)
Sep 2020
-
-$112.82M(-219.7%)
-$170.19M(+0.5%)
Jun 2020
-
$94.26M(+26.0%)
-$169.42M(-52.2%)
Mar 2020
-$354.28M(+16.2%)
$74.83M(-133.0%)
-$354.28M(-31.4%)
Dec 2019
-
-$226.45M(+102.1%)
-$516.13M(+18.9%)
Sep 2019
-
-$112.05M(+23.7%)
-$434.18M(+5.1%)
Jun 2019
-
-$90.61M(+4.1%)
-$413.28M(+35.6%)
Mar 2019
-$304.86M(+342.7%)
-$87.02M(-39.8%)
-$304.86M(-2.1%)
Dec 2018
-
-$144.51M(+58.5%)
-$311.40M(+135.6%)
Sep 2018
-
-$91.15M(-611.7%)
-$132.16M(+85.9%)
Jun 2018
-
$17.81M(-119.0%)
-$71.07M(+3.2%)
Mar 2018
-$68.87M(+25.1%)
-$93.55M(-369.3%)
-$68.87M(-19.3%)
Dec 2017
-
$34.73M(-215.5%)
-$85.33M(-50.7%)
Sep 2017
-
-$30.07M(-250.2%)
-$173.03M(-216.4%)
Jun 2017
-
$20.02M(-118.2%)
$148.67M(-370.0%)
Mar 2017
-$55.06M(-78.8%)
-$110.01M(+107.7%)
-$55.06M(-255.9%)
Dec 2016
-
-$52.97M(-118.2%)
$35.32M(-15.5%)
Sep 2016
-
$291.63M(-258.7%)
$41.81M(-110.6%)
Jun 2016
-
-$183.71M(+835.5%)
-$393.64M(+51.5%)
Mar 2016
-$259.89M(+285.8%)
-$19.64M(-57.7%)
-$259.89M(+48.8%)
Dec 2015
-
-$46.47M(-67.7%)
-$174.67M(+78.2%)
Sep 2015
-
-$143.82M(+187.9%)
-$98.01M(+60.2%)
Jun 2015
-
-$49.96M(-176.2%)
-$61.17M(-9.2%)
Mar 2015
-$67.37M(+1770.6%)
$65.58M(+117.2%)
-$67.37M(-65.3%)
Dec 2014
-
$30.19M(-128.2%)
-$194.10M(-10.2%)
Sep 2014
-
-$106.98M(+90.5%)
-$216.10M(+66.0%)
Jun 2014
-
-$56.16M(-8.2%)
-$130.19M(+3515.2%)
Mar 2014
-$3.60M(-89.1%)
-$61.15M(-846.2%)
-$3.60M(-109.0%)
Dec 2013
-
$8.19M(-138.9%)
$39.90M(+5.6%)
Sep 2013
-
-$21.08M(-129.9%)
$37.80M(+113.9%)
Jun 2013
-
$70.43M(-499.1%)
$17.67M(-153.6%)
DateAnnualQuarterlyTTM
Mar 2013
-$32.97M(-142.1%)
-$17.65M(-389.7%)
-$32.97M(-73.0%)
Dec 2012
-
$6.09M(-114.8%)
-$121.99M(+263.6%)
Sep 2012
-
-$41.21M(-308.2%)
-$33.55M(-135.9%)
Jun 2012
-
$19.79M(-118.6%)
$93.43M(+19.4%)
Mar 2012
$78.27M(-1045.2%)
-$106.67M(-212.8%)
$78.27M(-70.4%)
Dec 2011
-
$94.53M(+10.2%)
$264.19M(+75.8%)
Sep 2011
-
$85.78M(+1751.1%)
$150.28M(+1690.8%)
Jun 2011
-
$4.63M(-94.2%)
$8.39M(-201.3%)
Mar 2011
-$8.28M(-92.6%)
$79.25M(-508.9%)
-$8.28M(-57.5%)
Dec 2010
-
-$19.38M(-65.5%)
-$19.48M(-51.3%)
Sep 2010
-
-$56.11M(+366.1%)
-$40.03M(-6.9%)
Jun 2010
-
-$12.04M(-117.7%)
-$42.98M(-61.6%)
Mar 2010
-$112.05M(+103.5%)
$68.05M(-270.4%)
-$112.05M(-48.0%)
Dec 2009
-
-$39.93M(-32.4%)
-$215.54M(+21.3%)
Sep 2009
-
-$59.07M(-27.2%)
-$177.66M(+125.4%)
Jun 2009
-
-$81.10M(+128.9%)
-$78.82M(+43.1%)
Mar 2009
-$55.06M(-71.9%)
-$35.44M(+1618.6%)
-$55.06M(+600.4%)
Dec 2008
-
-$2.06M(-105.2%)
-$7.86M(-46.0%)
Sep 2008
-
$39.78M(-169.4%)
-$14.55M(-72.1%)
Jun 2008
-
-$57.34M(-587.5%)
-$52.10M(-73.5%)
Mar 2008
-$196.26M(-603.1%)
$11.76M(-234.3%)
-$196.26M(-29.4%)
Dec 2007
-
-$8.75M(-492.2%)
-$277.89M(+94.2%)
Sep 2007
-
$2.23M(-101.1%)
-$143.12M(-15.3%)
Jun 2007
-
-$201.50M(+188.4%)
-$168.90M(-532.9%)
Mar 2007
$39.01M(-93.7%)
-$69.86M(-155.4%)
$39.01M(-94.6%)
Dec 2006
-
$126.01M(-635.2%)
$716.91M(+23.2%)
Sep 2006
-
-$23.55M(-467.4%)
$582.04M(-2.8%)
Jun 2006
-
$6.41M(-98.9%)
$598.61M(-3.2%)
Mar 2006
$618.26M(+1333.4%)
$608.03M(-6969.3%)
$618.26M(+2138.1%)
Dec 2005
-
-$8.85M(+26.8%)
$27.62M(-46.7%)
Sep 2005
-
-$6.98M(-126.8%)
$51.79M(+75.0%)
Jun 2005
-
$26.07M(+49.9%)
$29.60M(-31.4%)
Mar 2005
$43.13M(-625.6%)
$17.39M(+13.6%)
$43.13M(+47.9%)
Dec 2004
-
$15.31M(-152.5%)
$29.17M(+197.4%)
Sep 2004
-
-$29.18M(-173.7%)
$9.81M(-69.6%)
Jun 2004
-
$39.60M(+1056.0%)
$32.27M(-493.2%)
Mar 2004
-$8.21M(+160.5%)
$3.43M(-184.6%)
-$8.21M(-13.9%)
Dec 2003
-
-$4.05M(-39.7%)
-$9.53M(+44.6%)
Sep 2003
-
-$6.71M(+668.6%)
-$6.59M(+72.5%)
Jun 2003
-
-$873.20K(-141.5%)
-$3.82M(+21.3%)
Mar 2003
-$3.15M(-110.6%)
$2.10M(-289.5%)
-$3.15M(-53.7%)
Dec 2002
-
-$1.11M(-71.8%)
-$6.80M(-69.5%)
Sep 2002
-
-$3.94M(+1847.3%)
-$22.27M(+4.1%)
Jun 2002
-
-$202.40K(-86.9%)
-$21.39M(-171.9%)
Mar 2002
$29.73M(-1656.4%)
-$1.55M(-90.7%)
$29.73M(-4.9%)
Dec 2001
-
-$16.58M(+441.9%)
$31.28M(-34.6%)
Sep 2001
-
-$3.06M(-106.0%)
$47.86M(-6.0%)
Jun 2001
-
$50.92M
$50.92M
Mar 2001
-$1.91M
-
-

FAQ

  • What is Dr Reddys Laboratories Limited annual cash flow from financing activities?
  • What is the all time high annual CFF for Dr Reddys Laboratories Limited?
  • What is Dr Reddys Laboratories Limited annual CFF year-on-year change?
  • What is Dr Reddys Laboratories Limited quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Dr Reddys Laboratories Limited?
  • What is Dr Reddys Laboratories Limited quarterly CFF year-on-year change?
  • What is Dr Reddys Laboratories Limited TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Dr Reddys Laboratories Limited?
  • What is Dr Reddys Laboratories Limited TTM CFF year-on-year change?

What is Dr Reddys Laboratories Limited annual cash flow from financing activities?

The current annual CFF of RDY is $140.23M

What is the all time high annual CFF for Dr Reddys Laboratories Limited?

Dr Reddys Laboratories Limited all-time high annual cash flow from financing activities is $618.26M

What is Dr Reddys Laboratories Limited annual CFF year-on-year change?

Over the past year, RDY annual cash flow from financing activities has changed by +$185.68M (+408.49%)

What is Dr Reddys Laboratories Limited quarterly cash flow from financing activities?

The current quarterly CFF of RDY is -$170.86M

What is the all time high quarterly CFF for Dr Reddys Laboratories Limited?

Dr Reddys Laboratories Limited all-time high quarterly cash flow from financing activities is $608.03M

What is Dr Reddys Laboratories Limited quarterly CFF year-on-year change?

Over the past year, RDY quarterly cash flow from financing activities has changed by -$164.19M (-2464.08%)

What is Dr Reddys Laboratories Limited TTM cash flow from financing activities?

The current TTM CFF of RDY is $140.23M

What is the all time high TTM CFF for Dr Reddys Laboratories Limited?

Dr Reddys Laboratories Limited all-time high TTM cash flow from financing activities is $716.91M

What is Dr Reddys Laboratories Limited TTM CFF year-on-year change?

Over the past year, RDY TTM cash flow from financing activities has changed by +$185.68M (+408.50%)
On this page